Consolidated Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Revenues:
Royalties	$ 0	$ 669,310
Revenues	0	669,310
Costs and expenses:
Research and development	2,749,430	2,375,339
General and administrative	2,990,589	2,797,971
Costs and expenses	5,740,019	5,173,310
Interest (income) expense, net	(1,658)	10,041,224
Net loss	(5,738,361)	(14,545,224)
Dividends on Series A convertible preferred stock	0	(335,000)
Net loss attributable to common shareholders	$ (5,738,361)	$ (14,880,224)
Net loss per share (basic and diluted) (in dollars Per share)	$ (0.22)	$ (0.78)
Weighted average number of common shares outstanding (basic and diluted) (in shares)	26,125,852	19,055,064